Xenetic Biosciences, Inc. (XBIO) stock
XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.61+0.12 (+8.05%)
Close on Nov 17, 2026Market cap $3.77MP/E –Yield –
Xenetic Biosciences cash
Cash and short-term investments held at the end of each period.
Xenetic Biosciences's cash was $6.47M at Jun 30, 2026. For fiscal 2025 it was $7.88M, up 27.9% from the year before. Over ten years it grew 50.5% a year on average. The highest annual figure on record is $18.24M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.88M | +27.9% |
| FY2024 | Dec 31, 2024 | $6.17M | -31.4% |
| FY2023 | Dec 31, 2023 | $8.98M | -31.4% |
| FY2022 | Dec 31, 2022 | $13.10M | -28.2% |
| FY2021 | Dec 31, 2021 | $18.24M | +58.3% |
| FY2020 | Dec 31, 2020 | $11.53M | +11.2% |
| FY2019 | Dec 31, 2019 | $10.37M | +1524.8% |
| FY2018 | Dec 31, 2018 | $638.12K | -88.6% |
| FY2017 | Dec 31, 2017 | $5.60M | +36.1% |
| FY2016 | Dec 31, 2016 | $4.11M | +3011.8% |
| FY2015 | Dec 31, 2015 | $132.23K | -94.7% |
| FY2014 | Dec 31, 2014 | $2.51M | -48.2% |
| FY2013 | Dec 31, 2013 | $4.84M | -56.5% |
| FY2012 | Dec 31, 2012 | $11.14M | -34.9% |
| FY2011 | Dec 31, 2011 | $17.12M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.47M | +35.4% |
| Q1 FY2026 | Mar 31, 2026 | $7.35M | +42.3% |
| Q4 FY2025 | Dec 31, 2025 | $7.88M | +27.9% |
| Q3 FY2025 | Sep 30, 2025 | $4.12M | -39.7% |
| Q2 FY2025 | Jun 30, 2025 | $4.78M | -34.5% |
| Q1 FY2025 | Mar 31, 2025 | $5.16M | -34.0% |
| Q4 FY2024 | Dec 31, 2024 | $6.17M | -31.4% |
| Q3 FY2024 | Sep 30, 2024 | $6.84M | -30.0% |
| Q2 FY2024 | Jun 30, 2024 | $7.30M | -32.0% |
| Q1 FY2024 | Mar 31, 2024 | $7.82M | -34.8% |
| Q4 FY2023 | Dec 31, 2023 | $8.98M | -31.4% |
| Q3 FY2023 | Sep 30, 2023 | $9.78M | -34.5% |
| Q2 FY2023 | Jun 30, 2023 | $10.73M | -33.6% |
| Q1 FY2023 | Mar 31, 2023 | $11.99M | -34.3% |
| Q4 FY2022 | Dec 31, 2022 | $13.10M | -33.5% |
| Q2 FY2022 | Jun 30, 2022 | $14.93M | +60.8% |
| Q1 FY2022 | Mar 31, 2022 | $16.16M | +61.4% |
| Q4 FY2021 | Dec 31, 2021 | $18.24M | +58.3% |
| Q3 FY2021 | Sep 30, 2021 | $19.70M | +179.3% |
| Q2 FY2021 | Jun 30, 2021 | $9.28M | +15.1% |
| Q1 FY2021 | Mar 31, 2021 | $10.01M | +6.8% |
| Q4 FY2020 | Dec 31, 2020 | $11.53M | +11.2% |
| Q3 FY2020 | Sep 30, 2020 | $7.05M | -41.4% |
| Q2 FY2020 | Jun 30, 2020 | $8.07M | +680.0% |
| Q1 FY2020 | Mar 31, 2020 | $9.37M | +349.3% |
| Q4 FY2019 | Dec 31, 2019 | $10.37M | +1524.8% |
| Q3 FY2019 | Sep 30, 2019 | $12.04M | +617.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.03M | -68.9% |
| Q1 FY2019 | Mar 31, 2019 | $2.08M | -47.0% |
| Q4 FY2018 | Dec 31, 2018 | $638.12K | -88.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.68M | +120.6% |
| Q2 FY2018 | Jun 30, 2018 | $3.32M | +38.6% |
| Q1 FY2018 | Mar 31, 2018 | $3.93M | -9.0% |
| Q4 FY2017 | Dec 31, 2017 | $5.60M | +36.1% |
| Q3 FY2017 | Sep 30, 2017 | $761.26K | +259.3% |
| Q2 FY2017 | Jun 30, 2017 | $2.40M | +896.1% |
| Q1 FY2017 | Mar 31, 2017 | $4.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.11M | – |
| Q3 FY2016 | Sep 30, 2016 | $211.90K | – |
| Q2 FY2016 | Jun 30, 2016 | $240.79K | – |
See a number that looks wrong?